Wednesday, July 2, 2025

Canaccord Raises Trulieve Price Target To $75 From $60

The last two weeks have been quite an enjoyable time for U.S cannabis sector investors. On January 5th, we had the Georgia run-offs. Roughly three days later, we found out that both Democratic party members won their reelection campaigns. Although still going on, many analysts have already come out with their 2021 outlooks, including updated forward-looking guidance for many of the U.S companies. Finally, in the last two weeks, U.S cannabis companies have raised close to C$1 billion in sales from issuing stock. To most, this shows that there is true institutional investor demand for these sorts of companies.

This morning, Canaccord came out with their updated valuations for three large multi-state operators. Within the note, they raised their 12-month price target on Trulieve Cannabis (CSE: TRUL) to C$75 from C$60, while reiterating their Speculative Buy rating on the company.

Trulieve currently has 14 analysts covering the company with a weighted 12-month price target of C$55.83. This is up from the average at the start of the month, which was C$53.27. Two analysts have strong buys, while the remaining 12 have buy ratings on the company.

Derek Daly, Canaccord U.S cannabis analyst, said the primary reason for the price target increase is due to “the recent Democratic Senate win in Georgia and what we believe will be an acceleration of pro-cannabis legislation over the medium term.” He reiterates his claim that Trulieve is one of the best positioned MSO’s to capitalize on this regulatory move.

For the balance sheet, Dley says Trulieve has industry-leading EBITDA and EBITDA margins at $67.5 million and 49.5%, respectively. The company boasts $193 million in cash and generates continual free cash flow, which Dley writes, “leaves the company well-positioned to accelerate growth within its core markets in 2021.”

Trulieve maintains a dominant ~50% market share in its core market of Florida. Daly says that there was a 9% increase in patient count quarter over quarter. This increase “should allow Trulieve to continue to accelerate its revenue and EBITDA growth into 2021.”

Daly says that 2021 will be an exciting year for Trulieve, as the company gains exposure into Pennsylvania by acquiring PurePenn and Solevo. He writes Pennsylvania “is one of our preferred medical markets within the US. and expects the state to become the next of many fast-growing medical markets alongside the potential of the state approving recreational cannabis in the medium term.”

He ends the note by writing, “With Trulieve currently trading at 10.8x our 2022 EBITDA estimate and given Trulieve’s dominant and growing position in the attractive Florida market, and exposure to the high growth Pennsylvania and Massachusetts markets, we believe the shares are undervalued at current levels.”


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Gold Drilling Scaled to 60,000 Meters: How Big Can This Get? | Roger Rosmus – Goliath Resources

Baselode Energy To Acquire Forum Energy: The Merger Of Equals Deal

TriStar Gold: The Revised Castelo de Sonhos Prefeasibility Study

Recommended

ESGold To Expand Mine Building At Montauban In Advance Of Gold & Silver Production

Goliath Resources Expands 2025 Drill Program To 60,000 Metres

Related News

Lundin Mining: BMO Sees Estimates Missed In Q3 Results

On October 27, Lundin Gold Inc. (TSX: LUG) reported their third quarter 2021 results, the...

Saturday, October 30, 2021, 01:16:00 PM

Netflix: Second Quarter Earnings Estimates

Netflix (NASDAQ: NFLX) will be reporting their second quarter financial results on July 20th after...

Tuesday, July 20, 2021, 02:46:00 PM

Minera Alamos Sees Haywood Reiterate Targets Following Santana Gold Update

On May 31, Minera Alamos (TSXV: MAI) provided an update on their Santana Gold project....

Monday, June 6, 2022, 11:27:00 AM

Kinross Gold: Canaccord Lowers Target After Higher Than Expected Costs

On July 28, Kinross Gold Corporation (TSX: K) reported their second quarter results. The company...

Friday, August 6, 2021, 10:07:00 AM

Canopy Growth: Analysts Expect Q2 Revenues Of $142.5 Million

Canopy Growth Corp (TSX: WEED) (NASDAQ: CGC) announced that they will be reporting their fiscal...

Thursday, November 4, 2021, 03:16:00 PM